Technology
Health
Pharmaceutical

Checkpoint Therapeutics

$2.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-3.14%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CKPT and other stocks, options, ETFs, and crypto commission-free!

About CKPT

Checkpoint Therapeutics, Inc. Common Stock, also called Checkpoint Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Read More Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.

Employees
7
Headquarters
New York, New York
Founded
2014
Market Cap
102.98M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
77.17K
High Today
$2.85
Low Today
$2.67
Open Price
$2.85
Volume
23.92K
52 Week High
$5.20
52 Week Low
$1.50

Collections

Technology
Health
Pharmaceutical
Medical
Therapy
Biopharmaceutical
2017 IPO
US

CKPT Earnings

-$0.38
-$0.31
-$0.25
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.